학술논문

Transcriptional profiling of whole blood: a rich source of immune biomarkers in cancer.
Document Type
Article
Source
OncoImmunology. Jul2014, Vol. 3 Issue 7, pN.PAG-N.PAG. 1p.
Subject
*IMMUNOTHERAPY
*GENETIC transcription
*BLOOD testing
*BIOMARKERS
*IMMUNE response
*CANCER treatment
*MESSENGER RNA
Language
ISSN
2162-4011
Abstract
Immunotherapy is at the forefront of cancer treatment, and biomarkers are urgently needed to predict patient response to therapy. Recently, we discovered a 4-gene peripheral blood mRNA signature for prolonged survival in patients treated with tremelimumab. Peripheral blood mRNA is a readily accessible and under-utilized source of clinically relevant biomarkers. [ABSTRACT FROM PUBLISHER]